Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Brief Summary: This phase II trial is studying how well gamma-secretase/Notch signalling pathway inhibitor RO4929097 works in treating patients with stage IV melanoma. Gamma-secretase/Notch signalling pathway inhibitor RO4929097 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.